Evidence map›Paper›PMID 23876925›Full record

ReviewTrends in molecular medicine2013

A molecular mechanism for glaucoma: endoplasmic reticulum stress and the unfolded protein response.

Robert R H Anholt, Mary Anna Carbone

Open access · greenAbstract readReview
In one paragraph

Review in Trends in molecular medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Retinoid X receptor agonist 9CDHRA mitigates retinal ganglion cell apoptosis and neuroinflammation in a mouse model of glaucoma.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert R H AnholtDepartment of Biological Sciences and W.M. Keck Center for Behavioral Biology, North Carolina State University, Raleigh, NC 27695-7617, USA. Electronic address: anholt@ncsu.edu.
Mary Anna Carbone
North Carolina State University · US

Funding

Comparative Genomics of GlaucomaR01EY015873 · NEI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI ANHOLT, ROBERT R. H · 2005 to 2008
$2.0M
Oxidative stress and neurogenetic networks in DrosophilaRC1ES018255 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI ANHOLT, ROBERT R. H · 2009 to 2010
$716k
NEI NIH HHS R01 EY015873NIEHS NIH HHS RC1 ES018255
6 · The paper itself

Abstract

Primary open angle glaucoma (POAG) is a common late-onset neurodegenerative disease. Ocular hypertension represents a major risk factor, but POAG etiology remains poorly understood. Some cases of early-onset congenital glaucoma and adult POAG are linked to mutations in myocilin, a secreted protein of poorly defined function. Transgenic overexpression of myocilin in Drosophila and experiments in mice and human populations implicate the unfolded protein response (UPR) in the pathogenesis of glaucoma. We postulate that compromised ability of the UPR to eliminate misfolded mutant or damaged proteins, including myocilin, causes endoplasmic reticulum stress, resulting in functional impairment of trabecular meshwork cells that regulate intraocular pressure. This mechanism of POAG is reminiscent of other age-dependent neurodegenerative diseases that involve accumulation of protein aggregates.

Indexed as

Endoplasmic Reticulum StressUnfolded Protein ResponseAnimalsCytoskeletal ProteinsEye ProteinsGlaucomaGlycoproteinsHumansMyocilinNeurodegenerative DiseasesTranslational Research, BiomedicalCytoskeletal ProteinsEye ProteinsGlycoproteinsMyocilinmyocilinneurodegenerative diseaseocular hypertensionprimary open angle glaucoma

Identifiers

PMID23876925
PMCPMC3795998
OpenAlexW2083161608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.